Who.int [Internet]. The top 10 causes of death [actualizado may 2014; citado may 2015]. Disponible en: http://www.who.int/mediacentre/factsheets/fs310/en/.
Who.int [Internet]. Cardiovascular diseases [actualizado ene 2015; citado may 2015]. Disponible en: http://www.who.int/mediacentre/factsheets/fs317/en/.
Binh TQ, Phuong PT, Nhung BT, Tung do D. Metabolic syndrome among a middle-aged population in the Red River Delta region of Vietnam. BMC Endocr Disord 2014;14:77.
DOI: 10.1186/1472-6823-14-77
Feoli AM, Macagnan FE, Piovesan CH, Bodanese LC, Siqueira IR. Xanthine oxidase activity is associated with risk factors for cardiovascular disease and inflammatory and oxidative status markers in metabolic syndrome: effects of a single exercise session. Oxid Med Cell Longev 2014;2014:587083.
DOI: 10.1155/2014/587083
Chang YH, Hsieh MC, Wang CY, Lin KC, Lee YJ. Reassessing the benefits of statins in the prevention of cardiovascular disease in diabetic patients: a systematic review and meta-analysis. Rev Diabet Stud 2013;10(2-3):157-70.
Jenkins DJ, Kendall CW, Marchie A, Josse AR, Nguyen TH, Faulkner DA, et al. Almonds reduce biomarkers of lipid peroxidation in older hyperlipidemic subjects. J Nutr 2008;138(5):908-13.
DOI: 10.1093/jn/138.5.908
Nishi SK, Kendall CW, Bazinet RP, Bashyam B, Ireland CA, Augustin LS, et al. Nut consumption, serum fatty acid profile and estimated coronary heart disease risk in type 2 diabetes. Nutr Metab Cardiovasc Dis 2014;24(8):845- 52.
DOI: 10.1016/j.numecd.2014.04.001
Nishi SK, Kendall CW, Gascoyne AM, Bazinet RP, Bashyam B, Lapsley KG, et al. Effect of almond consumption on the serum fatty acid profile: a dose-response study. Br J Nutr 2014;112(7):1137-46.
DOI: 10.1017/S0007114514001640
Wang X, Ouyang Y, Liu J, Zhu M, Zhao G, Bao W, et al. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta analysis of prospective cohort studies. BMJ 2014;349:g4490.
Holmes MV, Dale CE, Zuccolo L, Silverwood RJ, Guo Y, Ye Z, et al. Association between alcohol and cardiovascular disease: Mendelian randomization analysis based on individual participant data. BMJ 2014;349:g4164.
Drogan D, Sheldrick AJ, Schütze M, Knüppel S, Andersohn F, di Giuseppe R. Alcohol consumption, genetic variants in alcohol deydrogenases, and risk of cardiovascular diseases: a prospective study and meta-analysis. PLoS One 2012;7(2):e32176.
Patra J, Taylor B, Irving H, Roerecke M, Baliunas D, Hohapatra S, et al. Alcohol consumption and the risk of morbidity and mortality for different stroke types-a systematic review and meta-analysis. BMC Public Health 2010;10:258.
DOI: 10.1186/1471-2458-10-258
Rückert IM, Schunk M, Holle R, Schipf S, Völzke H, Kluttig A. Blood pressure and lipid management fall far short in persons with type 2 diabetes: results from the DIAB-CORE Consortium including six German population-based studies. Cardiovasc Diabetol 2012;11:50.
DOI: 10.1186/1475-2840-11-50
Mejia-Lancheros C, Estruch R, Martínez-González MA, Salas-Salvadó J, Corella D, Gómez-Gracia E. Blood pressure values and depression in hypertensive individuals at high cardiovascular risk. BMC Cardiovasc Disord 2014;14:109.
DOI: 10.1186/1471-2261-14-109
Yeung A, Kiat H, Denniss AR, Cheema BS, Bensoussan A, Machliss B, et al. Randomised controlled trial of a 12 week yoga intervention on negative affective states, cardiovascular and cognitive function in post cardiac rehabilitation patients. BMC Complement Altern Med 2014;14:411.
DOI: 10.1186/1472-6882-14-411
Cramer H, Lauche R, Haller H, Steckhan N, Michalsen A, Dobos G. Effects of yoga on cardiovascular disease risk factors: a systematic review and meta-analysis. Int J Cardiol 2014;173(2):170-83.
DOI: 10.1016/j.ijcard.2014.02.017
Swardfager W, Herrmann N, Cornish S, Mazereeuw G, Marzolini S, Sham L, et al. Exercise intervention and inflammatory markers in coronary artery disease: a meta-analysis. Am Heart J 2012;163(4):666-76.
DOI: 10.1016/j.ahj.2011.12.017
Li J, Siegrist J. Physical activity and risk of cardiovascular disease: a meta-analysis of prospective cohort studies. Int J Environ Res Public Health 2012;9(2):391-407.
DOI: 10.3390/ijerph9020391
Semlitsch T, Jeitler K, Hemkens LG, Horvath K, Nagele E, Schuermann C, et al. Increasing physical activity for the treatment of hypertension: a systematic review and meta-analysis. Sports Med 2013;43(10):1009-23.
DOI: 10.1007/s40279-013-0065-6
Cornelissen VA, Smart NA. Exercise training for blood pressure: a systematic review and meta-analysis. J Am Heart Assoc 2013;2(1):e004473.
Varbo A, Benn M, Tybjaerg-Hansen A, Grande P, Nordestgaard BG. TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population. Arterioscler Thromb Vasc Biol 2011;31(2):451-7.
Montero D, Walther G, Benamo E, Pérez-Martín A, Vinet A. Effects of exercise training on arterial function in type 2 diabetes mellitus: a systematic review and meta-analysis. Sports Med 2013;43(11):1191-9.
Pattyn N, Cornelissen VA, Eshghi SR, Vanhees L. The effect of exercise on the cardiovascular risk factors constituting the metabolic syndrome: a meta-analysis of controlled trials. Sports Med 2013;43(2):121-33.
World Heart Federation. Types of heart disease observed in children and adolescents. 2012. Disponible en : http://www.world-heart federation.org/press/fact-sheets/cvd-in-children-and-youth/ (Consultado el 8 julio 2015).
Friedemann C, Heneghan C, Mahtani K, Thompson M, Perera R, Ward A. Cardiovascular disease risk in healthy children and its association with body mass index: systematic review and meta-analysis. BMJ 2012;345:e4759.
Jones MR, Tellez-Plaza M, Navas-Acien A. Smoking, menthol cigarettes and all-cause, cancer and cardiovascular mortality: evidence from the National Health and Nutrition Examination Survey (NHANES) and a meta-analysis. PLoS One 2013;8(10):e77941.
Mäkinen VP, Civelek M, Meng Q, Zhang B, Zhu J, Levian C, et al. Integrative genomics reveals novel molecular pathways and gene networks for coronary artery disease. PLoS Genet 2014;10(7):e1004502.
Patel RS, Asselbergs FW, Quyyumi AA, Palmer TM, Finan CI, Tragante V, et al. Genetic variants at chromosome 9p21 and risk of first versus subsequent coronary heart disease events: a systematic review and meta-analysis. J Am Coll Cardiol 2014;63(21):2234-45.
Zhou J, Xu L, Huang RS, Huang Y, Le Y, Jiang D, et al. Apolipoprotein A5 gene variants and the risk of coronary heart disease: a case-control study and meta-analysis. Mol Med Rep 2013;8(4):1175-82.
Pi Y, Zhang L, Yang Q, Li B, Guo L, Fang C, et al. Apolipoprotein A5 gene promoter region -1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis. Cerebrovasc Dis 2012;33(6):558-65.
Zhai G, Li , Zhu C. ApoA5 -1131T/C polymorphism is associated with coronary artery disease in a Chinese population: a meta-analysis. Clin Chem Lab Med 2011;49(3):535-9.
Ramakrishnan L, Sachdev HS, Sharma M, Abraham R, Prakash S, Gupta D, et al. Relationship of ApoA5, PPARϒ and HL gene variants with serial changes in childhood body mass index and coronary artery disease risk factors in young adulthood. Lipids Health Dis 2011;10:68.
Cui G, Li Z, Li R, Huang J, Wang H, Zhang L. A functional variant in ApoA5/A4/C3/A1 gene cluster contributes to elevated triglycerides and severity of CAD by interfering with microRNA 3201 binding efficiency. J Am Coll Cardiol 2014;64(3):267-77.
Wang QY, Wang WJ, Wu L, Liu L, Han LZ. Meta-analysis of APOE ε2 ε3/ε4 polymorphism and cerebral infarction. J Neural Transm 2013;120(10):1479-89.
Niu Wq, Qi Y. Meta-based evidence for apolipoprotein E epsilon2/epsilon3/epsilon4 polymorphism in association with hypertension among Chinese. J Hum Hypertens 2011;25(12):725-31.
De Kort SW, Hokken-Koelega AC. The PPAR-gamma Pro12Ala polymorphism associates with weight gain during GH-treatment in short children born small for gestational age. Eur J Endocrinol 2010;162(1):49-52.
Wang Y, Liu C. Quantitativa evaluation of common polymorphism (rs1801282) in the PPARϒ2 gene and hypertension susceptibility. Gene 2012;502(2):159-62.
Liu J, Wang LN. Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack. Cochrane Database Syst Rev 2014;1:CD010693.
Xu W, Xu J, Sun B, Chen H, Wang Y, Huang F, et al. The effect of PPARG genepolymorphisms on the risk of coronary heart disease: a meta-analysis. Mol Biol Rep 2013;40(2):875-84.
Ding S, Liu L, Zhuge QC, Yu Z, Zhang X, Xie J, et al. The meta analysis of the association of PPARG P12A, C161T polymorphism and coronary heart disease. Wien Klin Wochenschr 2012;124(19-20):671-7.
Zhang LN, Liu PP, Zhou J, Huang RS, Yuan F, Fei LJ, et al. Positive correlation between variants of lipid metabolism-related genes and coronary heart disease. Mol Med Rep 2013;8(1):260-6.
Demirkan A, Van Duijn CM, Ugocsai P, Isaacs A, Pramstaller PP, Liebisch G, et al. Genome-wide association study identifies novel loci associated with circulating phospho- and sphingolipid concentrations. PLoS Genet 2012;8(2):e1002490.
Edmondson AC, Braund PS, Stylianou IM, Khera AV, Nelson CP, Wolfe ML, et al. Dense genotyping of candidate gene loci identifies variants associated with high-density lipoprotein cholesterol. Circ Cardiovasc Genet 2011;4(2):145-55.
El-Sohemy A, Cornelis MC, Kabagambe EK, Campos H. Coffee, CYP1A2 genotype and risk of myocardial infarction. Genes Nutr 2007;2(1):155-6.
Simone B, de Stefano V, Leoncini E, Zacho J, Martinelli I, Emmerich J, et al. Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol 2013;28(8):621 47.
Dentali F, Ageno W, Bozzato S, Malato A, Gianni M, Squizzato A, et al. Role of factor V Leiden or G20210A prothrombin mutation in patients with symptomatic pulmonary embolism and deep vein thrombosis: a meta analysis of the literature. J Thromb Haemost 2012;10(4):732-7.
Angelakopoulou A, Shah T, Sofat R, Shah S, Berry DJ, Cooper J, et al. Comparative analysis of genome-wide association studies signals for lipids, diabetes, and coronary heart disease: Cardiovascular Biomarker Genetics Collaboration. Eur Heart J 2012;33(3):393-407.
Kim DS, Smith JA, Bielak LF, Wu CY, Sun YV, Sheedy PF, et al. The relationship between diastolic blood pressure and coronary artery calcification is dependent on single nucleotide polymorphisms on chromosome 9p21.3. BMC Med Genet 2014;15:89.
O’Donnell CJ, Kavousi M, Smith AV, Kardia SL, Feitosa MF, Hwang SJ, et al. Genome-wide association study for coronary artery calcification with followup in myocardial infarction. Circulation 2011;124(25):2855-64.
Svensson PA, Wahlstrand B, Olsson M, Froguel P, Falchi M, Bergman RN, et al. CDKN2B expression and subcutaneous adipose tissue expandability: possible influence of the 9p21 atherosclerosis locus. Biochem Biophys Res Commun 2014;446(4):1126-31.
Congrains A, Kamide K, Oguro R, Yasuda O, Miyata K, Yamamoto E, et al. Genetic variants at the 9p21 locus contribute to aterosclerosis through modulation of ANRIL and CDKN2A/B. Atherosclerosis 2012;220(2):449-55.
Kojima Y, Downing K, Kundu R, Miller C, Dewey F, Lancero H et al. Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis. J Clin Invest 2014;124(3):1083-97.
Li YY, Wu XY, Xu J, Qian Y, Zhou CW, Wang B. Apo A5 -1131T/C, FgB -455G/A, -148C/T, and CETP TaqIB gene polymorphisms and coronary artery disease in the Chinese population: a meta-analysis of 15,055 subjects. Mol Biol Rep 2013;40(2):1997-2014.
Zhang Z, Peng B, Gong RR, Gao LB, Du J, Fang DZ et al. Apolipoprotein A5 polymorphisms and risk of coronary artery disease: a meta-analysis. Biosci Trends 2011;5(4):165-172.
Anthopoulos PG, Hamodrakas SJ, Bagos PG. Apolipoprotein E polymorphisms and type 2 diabetes: a meta-analysis of 30 studies including 5423 cases and 8197 controls. Mol Genet Metab 2010;100(3):283-91.
Landázuri P, Loango N, Gallego ML, Restrepo B. Diferencias de sexo, edad y lípidos plasmáticos asociadas al polimorfismo de la apolipoproteína E en un grupo de escolares de Quindío, Colombia. Biomédica 2009;29:382-91.
Rannikmäe K, Kalaria RN, Greenberg SM, Chui HC, Schmitt FA, Samarasekera N, et al. APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis. J Neurol Neurosurg Psychiatry 2014;85(3):300-5.
Samarasekera N, Smith C, Al-Shahi-Salman R. The association between cerebral amyloid angiopathy and intracerebral haemorrhage: systematic review and meta-analysis. J Neurol Neurosyrg Psychiatry 2012;83(3):275-81.
Atabek ME, Özkul Y, Eklioglu BS, Kurtoglu S, Baykara M. Association between Apolipoprotein E polymorphism and subclinic atherosclerosis in patients with type 1 Diabetes Mellitus. J Clin Res Pediatr Endocrinol 2012;4(1):8-13.
Zhang MD, Gu W, Qiao SB, Zhu EJ, Zhao QM, Ly SZ. Apolipoprotein E genepolymorphism and risk for coronary heart disease in the Chinese population: a meta-analysis of 61 studies including 6634 cases and 6393 controls. PLoS One 2014;9(4):e95463.
Stoumpos S, Hamodrakas SJ, Anthopoulos PG, Bagos PG. The association between apolipoprotein E gene polymorphisms and essential hypertension: a meta-analysis of 45 studies inclugind 13,940 cases and 16,364 controls. J Hum Hypertens 2013;27(4):245-55.
Wu Z, Lou Y, Jin W, Liu Y, Lu L, Lu G. The C161T polymorphism in the peroxisome proliferator activated receptor gamma gene (PPARϒ) is associated with risk of coronary artery disease: a meta-analysis. Mol Biol Rep 2013;40(4):3101-12.
Donnelly LA, Van Zuydam NR, Zhou K, Tavendale R, Carr F, Maitland Van der Zee AH, et al. Robust association of the LPA locus with low density lipoprotein cholesterol lowering response to statin treatment in a meta-analysis of 30467 individuals from both randomized control trials and observational studies and association with coronary artery disease outcome during statin treatment. Pharmacogenet Genomics 2013;23(10):518-25.
Thanassoulis G, Campbell CY, Owens DS, Smith JG, Smith AV, Peloso GM, et al. Genetic associations with valvular calcification and aortic stenosis. N Engl J Med 2013;368(6):503-12.
Helgadottir A, Gretarsdottir S, Thorleifsson G, Holm H, Patel RS, Gudnason T. Apolipoprotein (a) genetic sequence variants associated with systematic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. J Am Coll Cardiol 2012;60(8):722-9.
Wojczynski MK, Li M, Bielak LF, Kerr KF, Reiner AP, Wong ND. Genetics of coronary artery calcification among African Americans, a meta-analysis. BMC Med Genet 2013;14:75.
Bozok Çetintaş V, Gündüz C. Association between polymorphism of MTHFR c.677C>T and risk of cardiovascular disease in Turkish population: a meta-analysis for 2,780 cases and 3,022 controls. Mol Biol Rep 2014;41(1):397-409.
Chen KH, Chen LL, Li WG, Fang Y, Huang GY. Maternal MTHFR C677T polymorphism and congenital heart defect risk in the Chinese Han population: a meta-analysis. Genet Mol Res 2013;12(4):6212-9.
Wang W, Wang Y, Gong F, Zhu W, Fu S. MTHFR C677T polymorphism and risk of congenital heart defects: evidence from 29 case-control and TDT studies. PLoS One 2013;8(3):e58041.
Van Beynum IM, Kapusta L, den Heijer M, Vermeulen SH, Kouwenberg M, Daniëls O, et al. Maternal MTHFR 677C>T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation. Eur Heart J 2006;27(8):981-7.
Zhang MJ, Li JC, Yin YW, Li BH, Liu Y, Liao SQ, et al. Association of MTHFR C677T polymorphism and risk of cerebrovascular disease in Chinese population: an updated meta-analysis. J Neurol 2014;261(5):925-35.
Wu YL, Hu CY, Lu SS, Gong FF, Feng F, Qian ZZ, et al. Association between methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polumorphisms and essential hypertension: a systematic review and meta-analysis. Metabolism 2014;63(12):1503-11.
Lv Q, Lu J, Wu W, Sun H, Zhang J. Association of the methylenetetrahydrofolate reductase gene A1298C polymorphism with stroke risk based on a meta-analysis. Genet Mol Res 2013;12(4):6882-94.
Cushman M, Rosendaal FR, Psaty BM, Cook EF, Valliere J, Kuller LH, et al. Factor V Leiden is not a risk factor for arterial vascular disease in the elderly: results from the Cardiovascular Health Study. Thromb Haemost 1998;79(5):912-5.
Jiang B, Ryan KA, Hamedani A, Cheng Y, Sparks MJ, Koontz D, et al. Prothrombin G20210A mutation is associated with young-onset stroke: the genetics of early-onset stroke study and meta-analysis. Stroke 2014;45(4):961-7.
Simchen MJ, Goldstein G, Lubetsky A, Strauss T, Schiff E, Kenet G. Factor V Leiden and antiphospholipid antibodies in either mother or infants increase the risk for perinatal arterial ischemic stroke. Stroke 2009;40(1):65-70.
Sidloff DA, Stather PW, Choke E, Bown MJ, Sayers RD. A systematic review and meta-analysis of the association between markers of hemostasis and abdominal aortic aneurysm presence and size. J Vasc Surg 2014;59(2):528-35.
D’Andrea G, D’Ambrosi RL, Di Perna P, Chetta M, Santacroce R, Brancaccio V, et al. A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin. Blood 2005;105(2):645-9.
Liew AY, Eikelboom JW, Connolly SJ, O’ Donnell M, Hart RG. Efficacy and safety of warfarin vs. antiplatelet therapy in patients with systolic heart failure and sinus rhythm: a systematic review and meta-analysis of randomized controlled trials. Int J Stroke 2014;9(2):199-206.
Sardar P, Chatterjee S, Wu WC, Lichstein E, Ghosh J, Aikat S, et al. New oral anticoagulants are not superior to warfarin in secondary prevention of stroke or transient ischemic attacks, but lower the risk of intracranial bleeding: insights from a meta-analysis and indirect treatment comparisons. PLoS One 2013;8(10):e77694.
Yang L, Ge W, Yu F, Zhu H. Impact of VKORC1 gene polymorphism on interindividual and interethnic warfarin dosage requirement--a systematic review and meta-analysis. Thromb Res 2010;125(4):e159-66.
Yung C, Wan AZ, Zukurnai Y, Siew HG. A new nested allele-specific multiplex polymerase chain reaction method for haplotyping of VKORC1 gene to predict warfarin sensitivity. BioMed Research International 2014;2014:316310.
Zhang H, Yang L, Feng Q, Fan Y, Zheng H, He Y. Association between VKORC1 gene polymorphisms and ischemic cerebrovascular disease in Chinese Han population. J Mol Neurosci 2014;53(2):166-70.
DOI: 10.1007/s12031-014-0259-x